DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award
ID: 354261Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Procurement Contract

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354261
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Clinical Trial Award (CTA) to support clinical trials aimed at improving the treatment and prevention of traumatic brain injuries (TBI) and psychological health conditions among military personnel and veterans. This funding opportunity encourages proposals for clinical trials that can lead to significant advancements in healthcare products, technologies, and practice guidelines, with a total estimated funding of $58.9 million to support approximately 18 awards. Key deadlines include a pre-application submission by June 27, 2024, and a full application submission by October 3, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524STBIPHRP1_CTA_BAA_GG.pdf
    The Department of Defense (DOD) has announced the FY24 Traumatic Brain Injury and Psychological Health Clinical Trial Award (CTA) under its Broad Agency Announcement for Extramural Research. This program aims to enhance the prevention and treatment of traumatic brain injuries (TBI) and psychological health conditions among military personnel and veterans. The funding opportunity encourages research proposals focused on clinical trials that can provide significant advancements in these areas, with a total appropriation of $175 million for FY24. Key deadlines include the pre-application submission by June 27, 2024, and full application submission by October 3, 2024. Eligible applicants include extramural organizations such as academic institutions and biotechnology companies. Specific focus areas for research include preventive and assessment solutions for psychological conditions and TBIs, as well as novel treatment interventions. The application process is a two-step procedure, mandating a pre-application followed by a full application to be submitted through designated platforms. The CTA aims to foster collaborations between researchers and community organizations, employing Community-Based Participatory Research (CBPR) methods to ensure relevance and effectiveness in addressing the needs of service members and their families. Overall, this initiative reflects DOD’s commitment to improving health outcomes through robust research and clinical applications.
    Similar Opportunities
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Tactical Behaviors for Autonomous Maneuver
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Tactical Behaviors for Autonomous Maneuver Collaborative Research Program (TBAM-CRP) aimed at enhancing the capabilities of robotic and autonomous systems (RAS) for military operations in complex environments. This program seeks proposals that develop coordinated and adaptive behaviors for small groups of autonomous agents, focusing on innovative maneuver tactics and strategies to operate effectively in multi-domain operations against peer adversaries. The TBAM-CRP is critical for advancing military capabilities, leveraging new technologies in robotics and autonomous systems to improve situational awareness and operational effectiveness on the battlefield. Interested applicants, including institutions of higher education and for-profit organizations, are invited to submit proposals by April 24, 2024, with funding amounts ranging from $100,000 to $2.3 million available per award. For further inquiries, applicants can contact Christopher D. Justice at usarmy.adelphi.devcom-arl.mbx.tbam-crp-questions@army.mil.
    Airman Readiness Medical Research (ARMR) Hybrid BAA
    Air Force -- Research Lab
    The Air Force Research Laboratory (AFRL) is soliciting proposals for the Airman Readiness Medical Research (ARMR) program through a Hybrid Broad Agency Announcement (BAA) designated FA8650-20-S-6008. The primary objectives of this initiative are to conduct medical research aimed at optimizing the health and performance of Airmen, focusing on ensuring medical availability and understanding the effects of various operational environments on Airman well-being. This program is critical for enhancing the operational readiness of military personnel, particularly in high-demand mission scenarios, with key research areas including aeromedical evacuation, cognitive performance, and exposure health. The total funding available for this program is estimated at $480 million, with individual awards ranging from $50,000 to $49 million. Interested parties are encouraged to submit white papers by May 1, 2025, and can direct inquiries to Amber A. Taylor at amber.taylor.9@us.af.mil.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for clinical studies aimed at advancing next-generation devices for recording and modulation in the human central nervous system, under the BRAIN Initiative. This initiative seeks to support small clinical trials that provide critical data necessary for the development of devices intended to treat central nervous system disorders, particularly those requiring an Investigational Device Exemption (IDE) from the FDA. The funding is crucial for enhancing neurotechnology and improving treatment outcomes, with NIH planning to allocate approximately $10 million annually for 5 to 7 awards, each with a maximum budget of $1.5 million per year for up to five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by September 28, 2026.
    US Army Combat Capabilities Development Command Broad Agency Announcement
    ACC APG - Natick
    The US Army Combat Capabilities Development Command (CCDC) is inviting proposals through its Broad Agency Announcement (BAA) for research and development funding, managed by the ACC APG - Natick. This opportunity allows unrestricted applicants to submit white papers and proposals for grants and assistance agreements, focusing on various areas of interest outlined in the BAA solicitation document. The initiative is crucial for advancing the capabilities of the Army, with an expected 50 awards to be made. Interested parties should note that the submission deadline is February 28, 2025, and can reach out to Shawn P. Haubner at shawn.p.haubner.civ@mail.mil or by phone at 508-206-2067 for further information.
    UNITED STATES ARMY RESEARCH INSTITUTE FOR THE BEHAVIORAL AND SOCIAL SCIENCES (ARI) BROAD AGENCY ANNOUNCEMENT FOR BASIC, APPLIED, AND ADVANCED SCIENTIFIC RESEARCH
    Dept of the Army -- Materiel Command
    The Department of the Army, through the United States Army Research Institute for the Behavioral and Social Sciences (ARI), has issued a Broad Agency Announcement (BAA) for Basic, Applied, and Advanced Scientific Research, effective from May 1, 2023, to April 30, 2028. This initiative aims to solicit proposals for research and development in areas such as personnel assessment, leadership development, team dynamics, and technology fluency, with a focus on enhancing Army readiness and performance through innovative approaches to talent management. Eligible applicants include institutions of higher education, non-profit organizations, and for-profit entities, while government entities are excluded from prime contracts. Interested parties should submit white papers to streamline the proposal process, with a total of approximately 1,000 awards expected. For further inquiries, applicants can contact Wilveria A. Sanders at wilveria.a.sanders.civ@army.mil, and proposals must be submitted by April 30, 2028.
    Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for research projects aimed at evaluating the effectiveness of post-acute interventions and services for mental health conditions affecting youth, adults, and older adults. This initiative encourages clinical trials designed to assess therapeutic strategies that consolidate treatment gains, manage residual symptoms, prevent relapse, and enhance treatment adherence, with a focus on producing statistically powered studies that address chronic or relapsing mental health issues. The program emphasizes the importance of improving long-term mental health outcomes, particularly for underserved populations, and applications are open to a diverse range of eligible entities, including educational institutions and community organizations. Interested applicants should note that the deadline for submissions is January 25, 2025, and can find further details and guidelines at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a funding opportunity titled "Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes." This initiative aims to support research projects that evaluate the effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health conditions affecting various age groups, with a focus on clinical trials that assess long-term recovery and treatment adherence. The funding opportunity is open to a diverse range of applicants, including higher education institutions and community-based organizations, with a maximum project period of five years. Interested parties should note that the application deadline is January 7, 2028, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-207.html.